6-30914859-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020442.6(VARS2):c.23C>A(p.Ser8Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,612,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020442.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VARS2 | NM_020442.6 | c.23C>A | p.Ser8Tyr | missense_variant | 2/30 | ENST00000676266.1 | NP_065175.4 | |
VARS2 | NM_001167734.2 | c.113C>A | p.Ser38Tyr | missense_variant | 2/30 | NP_001161206.1 | ||
VARS2 | NM_001167733.3 | c.-219-297C>A | intron_variant | NP_001161205.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VARS2 | ENST00000676266.1 | c.23C>A | p.Ser8Tyr | missense_variant | 2/30 | NM_020442.6 | ENSP00000502585.1 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000223 AC: 55AN: 246526Hom.: 0 AF XY: 0.000260 AC XY: 35AN XY: 134410
GnomAD4 exome AF: 0.000266 AC: 388AN: 1460764Hom.: 0 Cov.: 59 AF XY: 0.000267 AC XY: 194AN XY: 726698
GnomAD4 genome AF: 0.000309 AC: 47AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74342
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 28, 2021 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 09, 2022 | This sequence change replaces serine, which is neutral and polar, with tyrosine, which is neutral and polar, at codon 38 of the VARS2 protein (p.Ser38Tyr). This variant is present in population databases (rs145694863, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with VARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1300565). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 16, 2024 | BP4 - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2021 | The c.113C>A (p.S38Y) alteration is located in exon 2 (coding exon 2) of the VARS2 gene. This alteration results from a C to A substitution at nucleotide position 113, causing the serine (S) at amino acid position 38 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at